Angelos Koutras Selected Research

Angelos Koutras Research Topics

Disease

57	Neoplasms (Cancer) 12/2023 - 07/2002
54	Breast Neoplasms (Breast Cancer) 12/2023 - 03/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2007
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2007 - 08/2005
4	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2021 - 04/2019
3	Carcinoma (Carcinomatosis) 05/2019 - 06/2014
3	Adenocarcinoma 05/2019 - 01/2007
3	Neoplasm Metastasis (Metastasis) 05/2019 - 12/2016
3	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 04/2020 - 01/2007
2	Disease Progression 01/2018 - 07/2004
2	Thrombosis (Thrombus) 02/2016 - 06/2010
2	Anemia 02/2016 - 06/2003
1	Circulating Neoplastic Cells 12/2022
1	Residual Neoplasm 10/2022
1	Sarcoma (Soft Tissue Sarcoma) 10/2022
1	Kidney Neoplasms (Kidney Cancer) 05/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2021
1	Adenoma (Adenomas) 04/2018
1	Adenocarcinoma of Lung 12/2016

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2012
16	Messenger RNA (mRNA)IBA 03/2023 - 01/2012
15	Trastuzumab (Herceptin)FDA Link 10/2022 - 03/2013
15	ParaffinIBA 01/2020 - 01/2012
13	Biomarkers (Surrogate Marker)IBA 10/2022 - 09/2011
12	Formaldehyde (Formol)FDA Link 01/2020 - 01/2012
11	AnthracyclinesIBA 01/2022 - 01/2012
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 08/2005
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 01/2011
6	Docetaxel (Taxotere)FDA Link 12/2023 - 01/2007
6	ErbB Receptors (EGF Receptor)IBA 10/2022 - 05/2011
6	human ERBB2 proteinIBA 10/2022 - 01/2019
6	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2014
6	Hormones (Hormone)IBA 01/2016 - 01/2012
5	taxaneIBA 01/2020 - 01/2007
5	Cisplatin (Platino)FDA LinkGeneric 01/2007 - 08/2005
4	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 01/2012
4	Taxoids (Taxanes)IBA 01/2022 - 07/2014
4	Bevacizumab (Avastin)FDA Link 04/2019 - 09/2011
3	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2019 - 01/2015
3	Cyclin D1IBA 01/2019 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 05/2015
2	Tamoxifen FDA LinkGeneric 01/2022 - 08/2019
2	LigandsIBA 01/2022 - 01/2018
2	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2018
2	NivolumabIBA 01/2022 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021 - 12/2016
2	Protein Isoforms (Isoforms)IBA 04/2021 - 10/2014
2	Immune Checkpoint InhibitorsIBA 06/2020 - 05/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2020 - 01/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 02/2011
2	Estrogen ReceptorsIBA 08/2019 - 01/2012
2	TOR Serine-Threonine KinasesIBA 04/2019 - 01/2016
2	CyclinsIBA 01/2019 - 01/2017
2	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2018 - 01/2014
2	Vascular Endothelial Growth Factor CIBA 01/2018 - 09/2015
2	OsteopontinIBA 01/2017 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 01/2015 - 06/2014
2	Phosphotransferases (Kinase)IBA 01/2015 - 05/2011
2	ixabepilone (BMS 247550)FDA Link 10/2014 - 01/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2007 - 12/2005
2	PlatinumIBA 01/2007 - 01/2006
2	Vitamin E FDA LinkGeneric 11/2006 - 09/2006
1	antineoplaston A10 (A 10)IBA 11/2022
1	TNF Receptor-Associated Factor 3IBA 11/2022
1	Circulating Tumor DNAIBA 10/2022
1	Anaplastic Lymphoma KinaseIBA 10/2022
1	pertuzumabIBA 01/2022
1	LipofuscinIBA 01/2022
1	VinculinIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Gefitinib (Iressa)FDA Link 10/2021
1	CD40 AntigensIBA 01/2021
1	B-Cell Activation Factor ReceptorIBA 01/2021
1	Lymphotoxin beta ReceptorIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CytokinesIBA 01/2020
1	ChemokinesIBA 01/2020
1	cabazitaxel FDA Link 01/2020
1	Actins (F Actin)IBA 08/2019
1	temsirolimus FDA Link 04/2019
1	Monoclonal AntibodiesIBA 11/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2018
1	Cell-Free Nucleic AcidsIBA 04/2018

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 12/2023 - 07/2002
18	Adjuvant Chemotherapy 11/2022 - 01/2012
6	Therapeutics 10/2022 - 01/2007
2	Precision Medicine 10/2022 - 01/2020
2	Aftercare (After-Treatment) 10/2022 - 08/2019
2	Immunotherapy 01/2022 - 05/2020
2	Semiconductors 05/2016 - 01/2016
1	Molecular Targeted Therapy 10/2022
1	Radiotherapy 05/2021
1	Particle Accelerators 05/2021